AI assistant
BIOTRON LIMITED — Capital/Financing Update 2018
Jun 11, 2018
64528_rns_2018-06-11_7fa96ccd-8a8c-40b0-b474-7cb1bd945af5.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [269 x 43] intentionally omitted <==
Level 2, 66 Hunter Street SYDNEY NSW 2000 AUSTRALIA
Telephone: +61 2 9300 3344 Facsimile: +61 2 9221 6333 E-mail: [email protected] Website: www.biotron.com.au
12 June 2018
The Manager Companies ASX Limited 20 Bridge Street Sydney NSW 2000
(1 page by email)
Dear Madam
NEW ISSUE OVERSUBSCRIBED
The Directors are pleased to advise that the Company's offer of new securities, as detailed in the Prospectus dated 10 May 2018, has been well supported by the Company's shareholders and new investors with the issue being oversubscribed.
As detailed in the Company’s Appendix 3B – New Issue Announcement, Application for Quotation of Additional Securities dated 10 May 2018, a total of 98,078,690 fully paid ordinary shares and 98,078,690 options, each to acquire 1 fully paid ordinary share at any time up to 12 December 2019 for $0.05, will be issued by the Company.
The Directors acknowledge the ongoing support of the Company’s shareholders and new investors.
Yours sincerely
==> picture [87 x 56] intentionally omitted <==
Peter J. Nightingale Company Secretary
pjn9429
CPS Capital Group Pty Ltd was the Lead Manager and the Underwriter to the issue.